PRAVITINIB
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Jan 2025)
What this means for you
Registered since 29 May 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86755540
- Registration number
- 5481440
- Mark type
- Stylized text
- Filed
- 14 Sept 2015
- Published for opposition
- 08 Mar 2016
- Registered
- 29 May 2018
- Attorney of record
- Rashida Karmali
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, inflammation and inflammatory diseases, auto-immune diseases, ophthalmic diseases, angiogenesis-dependent diseases, ocular angiogenic disease, diabetic retinopathy and macular degeneration made in whole or significant part of tyrosine kinase inhibitors
Owner
- Tactical Therapeutics, Inc., New York, NY, US
- Tactical Therapeutics, Inc., New York, NY, US
- Tactical Therapeutics, Inc., New York, NY, US
Prosecution history
- 31 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 29 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 26 Apr 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Apr 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Apr 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Apr 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Apr 2018 — ASSIGNED TO LIE
- 27 Mar 2018 — NOTICE OF REVIVAL - E-MAILED
- 26 Mar 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2018 — PETITION TO REVIVE-GRANTED
- 26 Mar 2018 — TEAS PETITION TO REVIVE RECEIVED